FG Nexus Inc. (FGNX) CEO Kyle Cerminara reports new RSU grant and warrant holdings
Rhea-AI Filing Summary
FG Nexus Inc. director, CEO and Chairman Kyle Cerminara, a 10% owner, reported receiving 6,794 restricted stock units on 12/11/2025 as director fee payment in lieu of cash at a price of $0 per share. The RSUs vested on the grant date, and each RSU represents a right to one share of common stock, bringing his directly held stake to 153,321 shares of FG Nexus common stock.
He also reports indirect holdings of common stock through a 401(k) plan, his spouse, minor children, Cerminara Capital LLC, FG Financial Holdings LLC and Fundamental Global Holdings LLC. In addition, Cerminara Capital LLC holds 225,000 common stock purchase warrants with a $5 exercise price expiring on 09/05/2035. Pre-funded common stock purchase warrants described in the filing were automatically exercised on 09/05/2025 upon the effectiveness of amendments to the company’s articles of incorporation.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 6,794 | $0.00 | -- |
| holding | Common Stock Purchase Warrant | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| X | Pre - Funded Common Stock Purchase Warrant | 200,000 | $4.99 | $998K |
| X | Pre - Funded Common Stock Purchase Warrant | 100,000 | $4.99 | $499K |
| X | Pre - Funded Common Stock Purchase Warrant | 100,000 | $4.99 | $499K |
| X | Pre - Funded Common Stock Purchase Warrant | 200,000 | $4.99 | $998K |
Footnotes (1)
- Represents restricted stock units ("RSUs") granted under the 2021 Equity Incentive Plan as director fee payment in lieu of cash. All RSUs vested on grant date. Each RSU represents a contingent right to receive one share of common stock of the Company. FG Financial Holdings LLC ("FGFH") and Fundamental Global Holdings LLC ("FGH") beneficially own in the aggregate 529,965 and 100,000 shares of FG Nexus Common Stock, respectively. Fundamental Global GP LLC ("FGGP"), which is an affiliate of FGFH and FGH, may be deemed to be a beneficial owner of the securities disclosed as directly owned by FGFH and FGH. Due to Mr. Cerminara's position with FGGP and affiliated entities, Mr. Cerminara may be deemed to be beneficial owner of the securities disclosed as directly owned by FGFH and FGH. Mr. Cerminara disclaims beneficial ownership of the shares of FG Common Stock beneficially owned by FGFH, FGH, and FGGP except to the extent of his pecuniary interest therein. The Pre-Funded Common Stock Purchase Warrants were exercised automatically on September 5, 2025 upon the effectiveness of articles of amendment to the Company's amended and restated articles of incorporation.
FAQ
What insider transaction did FG Nexus (FGNX) report for Kyle Cerminara?
Kyle Cerminara reported acquiring 6,794 restricted stock units (RSUs) of FG Nexus Inc. on 12/11/2025. The RSUs were granted under the 2021 Equity Incentive Plan as director fee payment in lieu of cash and were priced at $0 per share.
What roles does Kyle Cerminara hold at FG Nexus Inc. (FGNX)?
According to the filing, Kyle Cerminara is a Director, a 10% Owner, and an Officer of FG Nexus Inc., serving as CEO and Chairman.
What warrants on FG Nexus (FGNX) stock are reported as beneficially owned?
The filing shows Cerminara Capital LLC holding 225,000 common stock purchase warrants with an exercise price of $5 per share, exercisable and expiring on 09/05/2035. These warrants are reported as indirectly beneficially owned by Kyle Cerminara through Cerminara Capital LLC.
What does it mean that the FG Nexus RSUs vested on the grant date?
The filing notes that all RSUs vested on the grant date. This means that on 12/11/2025, Kyle Cerminara’s right to receive the related FG Nexus common shares became fully earned, with each RSU representing a contingent right to one share of the company’s common stock.